Glooko makes its management app free to any person with diabetes

▤ Summary

Glooko has made its mobile app free for any person with diabetes, ditching the subscription fees that had applied to users who were not sponsored through their provider, health plan or employer. The move comes on the heels of announcements promising that the 2015 Fierce 15 company’s product will be compatible with platforms such as Senseonics’ implantable, long-term continuous glucose monitoring hardware, as well as the upcoming connected insulin pens from Novo Nordisk. While one-time hardware costs may still apply, Glooko’s free version will include all the previously available features, including helping users track their glucose levels and spot trends connected to synced food, exercise and medication data. “I am thrilled we are removing the subscription fee for users of the mobile app—this will allow anyone who wants to use Glooko for self-management to be able to do so,” CEO Russ Johannesson said in a statement, adding that it will also allow providers to monitor larger patient populations. “Glooko has a large database of millions of users who are now able to see a clearer picture of their glucose profiles by integrating Eversense CGM data,” said Senseonics President and CEO Tim Goodnow.

▦ Linked Companies

Glooko, Inc.

$10M to $25M